News
"IRB approval marks an important milestone towards the launch of our MIRACLE pivotal Phase 3 trial of Annamycin in AML patients. Our team is focused on getting clinical trial sites up and running ...
In a phase 3, double-blind trial ... The protocol was approved by the institutional review board or independent ethics committee at each trial site. All the patients provided written informed ...
Repeated positive recommendation from Data Safety Monitoring Board ("DSMB") of pivotal Phase 3 study for lead clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results